Autoimmune hemolytic anemia is a heterogeneous disease with respect to the type of the
antibody involved and the absence or presence of an underlying condition. Treatment …

Among patients with SARS-CoV-2 infection (also known as COVID-19), pneumonia,
respiratory failure and acute respiratory distress syndrome are frequently encountered …

Autoimmune hemolytic anemia (AIHA) is a well known paraneoplastic phenomenon in
lymphoproliferative disorders but there are also a number of case reports of such an …

We retrospectively analyzed 77 patients with pathologically diagnosed angioimmunoblastic
T-cell lymphoma from a single city. There were 43 men and 34 women; the median age was …

We analyzed 108 cases of non-CLL non-Hodgkin lymphoma (NHL) associated with
autoimmune hemolytic anemia (AIHA)(+/− pure red cell aplasia (PRCA)) or Evans' …

A variety of circumstantial evidence from humans has implicated the B cell antigen receptor
(BCR) in the genesis of B cell lymphomas. We generated mouse models designed to test …

Autoimmune rheumatic diseases and lymphocytic malignancies are related and this
association is bidirectional. Lymphomas occur more frequently in the course of autoimmune …

Autoimmune hemolytic anemia (AIHA) may be frequently challenged by infectious
complications, mainly as a result of immunosuppressive treatments administered …

The presence of antinuclear autoantibodies (ANA) was investigated in a large cohort of
patients with non‐Hodgkin's lymphoma (NHL) in order to assess their frequency, specificity …

Paraneoplastic syndromes are manifestations of malignancies that have produced effects
that are distant from the primary tumor or metastases. Paraneoplastic syndromes are not …